Why timing, not demand, is now the biggest risk in skin cancer pathways

Rising demand in skin cancer services is already well understood. What is creating the greatest risk now is not demand itself, but timing.

Funding clarity, mobilisation and agreement on how capacity will be added often come together late in the process, leaving systems with fewer options once pressure is visible.

From our experience delivering teledermatology services at scale, the systems that cope best are not those facing less demand, but those that are able to act earlier. Early decisions create space to plan and integrate support in a way that fits local pathways. Later decisions narrow choices and make trade‑offs harder to avoid.

Demand is predictable, but the baseline has changed

Seasonal rises in suspected skin cancer referrals are predictable and most systems plan for them. What is different now is the level of demand services are carrying into those peaks.

Expanded screening and earlier diagnosis, as set out in the National Cancer Plan, are increasing activity earlier in the pathway. Combined with rising incidence, this means pressure no longer falls away outside summer months. Seasonal demand is being added to sustained activity rather than replacing it.

In this context, timing becomes critical. Systems that begin modelling demand and exploring options early retain flexibility. Where action starts only once pressure appears in waiting lists or performance data, choices are already narrower and responses are more constrained.

Late responses turn pressure into backlog

When decisions are delayed and capacity is constrained, services often default to short‑term protective measures. In skin cancer pathways, this frequently means pausing or deprioritising elective dermatology work to safeguard urgent cancer activity.

While understandable, this approach rarely resolves pressure. Once elective work is paused, backlog tends to persist. Services then spend the rest of the year chasing demand rather than recovering, with knock‑on effects across clinics, theatres and diagnostic services.

This is not a failure of effort or intent. It is a consequence of timing. Late responses force systems into reactive decisions that manage immediate risk but create longer‑term instability.

For systems looking to avoid pausing activity altogether, targeted insourcing support can provide additional resilience, helping maintain momentum across pathways while protecting clinical teams.

Early action creates control, not certainty

Planning earlier does not remove pressure from skin cancer services. Demand still exists and workforce constraints remain real. What early action consistently provides is control.

When support is explored early, whether through additional capacity or pathway‑based approaches such as teledermatology, systems have space to shape how that support fits locally. Workforce impact, governance and pathway alignment can be considered properly. Mobilisation becomes planned rather than rushed.

By contrast, support discussed late often feels like the only option left. Decisions are made under time pressure, with less opportunity to test assumptions or integrate change smoothly.

The difference between these scenarios is not demand. It is timing.

Timing as a system capability

National policy is rightly driving activity earlier in the pathway, with the aim of improving outcomes through faster diagnosis. For this ambition to translate into better flow rather than displaced pressure, diagnostic and specialist capacity needs to keep pace.

This requires systems to think about timing as a capability in its own right. Not just when activity happens, but when decisions are made, when funding clarity is reached and when mobilisation can realistically occur.

In our National Cancer Plan executive briefing, we explore this challenge further and set out readiness questions that help systems assess whether skin cancer pathways are prepared for rising demand, seasonal pressure and workforce constraints.

Moving from reaction to readiness

Skin cancer demand will continue to rise and seasonal surges will continue to occur. These are not problems to be solved once and moved on from.

The question for systems is whether timing allows pressure to be anticipated and managed, or whether it forces repeated reactive decisions that turn predictable demand into persistent backlog.

As skin cancer services face another summer of pressure, the difference between readiness and reaction is increasingly defined by when decisions are made, not simply by what decisions are taken. If your system is exploring how to address this challenge ahead of the next seasonal surge, we would be happy to discuss service options and timing considerations in more detail.